# The Study on the Pharmacokinetics of PEG-rhG-CSF in Children and Adolescents

> **NCT02953730** · PHASE4 · COMPLETED · sponsor: **Chinese Academy of Medical Sciences** · enrollment: 9 (actual)

## Conditions studied

- Acute Lymphoid Leukemia

## Interventions

- **DRUG:** PEG-rhG-CSF

## Key facts

- **NCT ID:** NCT02953730
- **Lead sponsor:** Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2016-06
- **Final completion:** —
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2016-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02953730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02953730, "The Study on the Pharmacokinetics of PEG-rhG-CSF in Children and Adolescents". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT02953730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
